Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2,000+ customers and partners access the world’s most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company, is headquartered in New York City and has offices around the world to meet the needs of its customers. For more information, go to https://www.medidata.com/

For more information, go to https://www.genomemedical.com/.

Univo IRB is an independent IRB committed to making research more accessible, inclusive, and human. Through our OneVerse® platform, we deliver fast, friendly, and fair reviews with clear communication and responsive support. We simplify the research experience—empowering sponsors and sites while always prioritizing participant protection. For more information, go to https://www.univo-group.com

The Center for Information and Study on Clinical Research Participation, Inc.’s (CISCRP) core mission is to provide accessible, relevant, useful, high-quality educational resources, programs, and services that increase awareness and understanding of the clinical research process; recognize and appreciate the unprecedented gift of participation in clinical trials; enhance and enrich the participation experience for patients and their families; and promote engagement and partnership between clinical research professionals, patients, and the public. To learn more, please visit https://www.ciscrp.org/

Precision for Medicine is the first global, precision-medicine, clinical research organization and a leader in complex clinical development. Our clients benefit from advanced technologies and new approaches that compress timelines, gain efficiencies and increase the probability of approval. Under one global roof, Precision has worldwide CRO services, integrated sophisticated biomarker capabilities, technical manufacturing solutions and more. With 7 specialty labs and 3500+ professionals worldwide, we help clients accelerate life-changing treatments and propel medicine forward. For more information, visit https://www.precisionformedicine.com/

Veristat is the scientific full-service CRO and consultancy integrating strategic planning, regulatory strategy, and clinical trial execution to rapidly advance the development, approval, and commercialization of your revolutionary therapies around the globe. The Science-First CRO™ — Veristat

AutoCruitment helps life sciences companies accelerate patient recruitment and enrollment through direct-to-patient targeting, enhanced qualification services, and dedicated site and patient engagement support. AutoCruitment has 10 years of delivering exceptional results to Pharmaceutical, Biotech, and Contract Research Organizations and has randomized over 13,700+ patients into clinical trials across more than 120 conditions and 37 countries. For more information, go to https://www.autocruitment.com/

Onc.AI is venture-capital backed company committed to developing robust, clinically validated, imaging-AI powered clinical management solutions focused on immunotherapy optimization. Using patented, radiomic-based AI models, Onc.AI has developed a clinical decision support platform using routine diagnostic imaging scans specifically for planning and guidance of first-line immune checkpoint inhibitors (ICI) treatment plans. For more information, go to https://onc.ai/

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

Sail Biomedicines, a Flagship Pioneering company, is generating tomorrow’s medicines today through the language of life. Sail’s platform combines first-in-category translatable circular RNA technology (Endless RNA™ or eRNA™), and proprietary programmable nanoparticles, utilizing natural components, to comprehensively program medicines for the first time. By leveraging its rapid prototyping and testing bioplatform, Sail is building a wealth of data, enabling unparalleled use of state-of-the-art AI techniques for the integrative design of RNA medicines with unprecedented performance and broad applicability. For more information, visit  https://www.sail.bio/